{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Latamoxef  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Latamoxef. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Latamoxef  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "latamoxef",
    "trial_2_text": "Latamoxef  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Latamoxef Supplement: 60 participants will take Latamoxef 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Latamoxef. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Latamoxef  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.18225260078907013,
      "78": 0.17861101031303406,
      "123": 0.14481066167354584,
      "177": 0.13381043076515198,
      "9": 0.11566554754972458,
      "173": 0.11468728631734848,
      "14": 0.1079038754105568,
      "20": 0.10780124366283417,
      "17": 0.1032026931643486,
      "189": 0.10166186839342117,
      "46": 0.09628798812627792,
      "68": 0.09460996091365814,
      "37": 0.09392636269330978,
      "2": 0.09356875717639923,
      "49": 0.09161198139190674,
      "188": 0.09016867727041245,
      "79": 0.08923304080963135,
      "228": 0.08764881640672684,
      "21": 0.08685005456209183,
      "350": 0.08306220173835754,
      "114": 0.0779857486486435,
      "29": 0.07374455779790878,
      "77": 0.07291094213724136,
      "76": 0.071490079164505,
      "200": 0.07129170745611191,
      "180": 0.06747724115848541,
      "64": 0.06611515581607819,
      "61": 0.06582670658826828,
      "193": 0.06375827640295029,
      "67": 0.06366365402936935,
      "30": 0.06355056166648865,
      "27": 0.062442846596241,
      "276": 0.06200125440955162,
      "269": 0.05520276725292206,
      "151": 0.054959774017333984,
      "147": 0.054137274622917175,
      "179": 0.05393371731042862,
      "85": 0.05369649827480316,
      "101": 0.05336344987154007,
      "243": 0.05213787034153938,
      "86": 0.051411233842372894,
      "104": 0.051323890686035156,
      "126": 0.0507345125079155,
      "72": 0.04794679582118988,
      "5": 0.04626193270087242,
      "239": 0.04608346149325371,
      "164": 0.04596426710486412,
      "282": 0.04470519721508026,
      "396": 0.04461356997489929,
      "194": 0.044421229511499405,
      "28": 0.04405303671956062,
      "122": 0.0438862070441246,
      "261": 0.04222117364406586,
      "131": 0.04169221594929695,
      "144": 0.04084814712405205,
      "35": 0.04057936370372772,
      "102": 0.039895474910736084,
      "1": 0.03906543552875519,
      "249": 0.03862956538796425,
      "96": 0.03772136569023132,
      "38": 0.03766249120235443,
      "69": 0.0367928110063076,
      "253": 0.03653151914477348,
      "139": 0.03642357140779495,
      "191": 0.03597787022590637,
      "142": 0.0353962779045105,
      "75": 0.03474276512861252,
      "18": 0.03344487026333809,
      "441": 0.033345118165016174,
      "355": 0.03330867737531662,
      "116": 0.03320877626538277,
      "288": 0.03306274488568306,
      "361": 0.032995712012052536,
      "130": 0.032617755234241486,
      "82": 0.03242809325456619,
      "234": 0.03231806680560112,
      "494": 0.0321144200861454,
      "262": 0.03151321783661842,
      "186": 0.03150085732340813,
      "92": 0.030994495376944542,
      "31": 0.030593005940318108,
      "33": 0.02889869548380375,
      "341": 0.028782039880752563,
      "97": 0.02854156866669655,
      "268": 0.028246913105249405,
      "394": 0.027003781870007515,
      "154": 0.026913471519947052,
      "100": 0.026631640270352364,
      "15": 0.026381054893136024,
      "286": 0.02611885406076908,
      "204": 0.02600884437561035,
      "466": 0.025948941707611084,
      "561": 0.025828158482909203,
      "121": 0.02557145617902279,
      "256": 0.025344466790556908,
      "400": 0.025327710434794426,
      "132": 0.02526785619556904,
      "356": 0.025250228121876717,
      "212": 0.025151796638965607,
      "183": 0.0249173566699028
    },
    "trial_2_ae": {
      "87": 0.18225260078907013,
      "78": 0.17861101031303406,
      "123": 0.14481066167354584,
      "177": 0.13381043076515198,
      "9": 0.11566554754972458,
      "173": 0.11468728631734848,
      "14": 0.1079038754105568,
      "20": 0.10780124366283417,
      "17": 0.1032026931643486,
      "189": 0.10166186839342117,
      "46": 0.09628798812627792,
      "68": 0.09460996091365814,
      "37": 0.09392636269330978,
      "2": 0.09356875717639923,
      "49": 0.09161198139190674,
      "188": 0.09016867727041245,
      "79": 0.08923304080963135,
      "228": 0.08764881640672684,
      "21": 0.08685005456209183,
      "350": 0.08306220173835754,
      "114": 0.0779857486486435,
      "29": 0.07374455779790878,
      "77": 0.07291094213724136,
      "76": 0.071490079164505,
      "200": 0.07129170745611191,
      "180": 0.06747724115848541,
      "64": 0.06611515581607819,
      "61": 0.06582670658826828,
      "193": 0.06375827640295029,
      "67": 0.06366365402936935,
      "30": 0.06355056166648865,
      "27": 0.062442846596241,
      "276": 0.06200125440955162,
      "269": 0.05520276725292206,
      "151": 0.054959774017333984,
      "147": 0.054137274622917175,
      "179": 0.05393371731042862,
      "85": 0.05369649827480316,
      "101": 0.05336344987154007,
      "243": 0.05213787034153938,
      "86": 0.051411233842372894,
      "104": 0.051323890686035156,
      "126": 0.0507345125079155,
      "72": 0.04794679582118988,
      "5": 0.04626193270087242,
      "239": 0.04608346149325371,
      "164": 0.04596426710486412,
      "282": 0.04470519721508026,
      "396": 0.04461356997489929,
      "194": 0.044421229511499405,
      "28": 0.04405303671956062,
      "122": 0.0438862070441246,
      "261": 0.04222117364406586,
      "131": 0.04169221594929695,
      "144": 0.04084814712405205,
      "35": 0.04057936370372772,
      "102": 0.039895474910736084,
      "1": 0.03906543552875519,
      "249": 0.03862956538796425,
      "96": 0.03772136569023132,
      "38": 0.03766249120235443,
      "69": 0.0367928110063076,
      "253": 0.03653151914477348,
      "139": 0.03642357140779495,
      "191": 0.03597787022590637,
      "142": 0.0353962779045105,
      "75": 0.03474276512861252,
      "18": 0.03344487026333809,
      "441": 0.033345118165016174,
      "355": 0.03330867737531662,
      "116": 0.03320877626538277,
      "288": 0.03306274488568306,
      "361": 0.032995712012052536,
      "130": 0.032617755234241486,
      "82": 0.03242809325456619,
      "234": 0.03231806680560112,
      "494": 0.0321144200861454,
      "262": 0.03151321783661842,
      "186": 0.03150085732340813,
      "92": 0.030994495376944542,
      "31": 0.030593005940318108,
      "33": 0.02889869548380375,
      "341": 0.028782039880752563,
      "97": 0.02854156866669655,
      "268": 0.028246913105249405,
      "394": 0.027003781870007515,
      "154": 0.026913471519947052,
      "100": 0.026631640270352364,
      "15": 0.026381054893136024,
      "286": 0.02611885406076908,
      "204": 0.02600884437561035,
      "466": 0.025948941707611084,
      "561": 0.025828158482909203,
      "121": 0.02557145617902279,
      "256": 0.025344466790556908,
      "400": 0.025327710434794426,
      "132": 0.02526785619556904,
      "356": 0.025250228121876717,
      "212": 0.025151796638965607,
      "183": 0.0249173566699028
    }
  },
  "safety": {
    "trial_1_safety": 0.35608017444610596,
    "trial_2_safety": 0.35608017444610596
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.48197227716445923
  }
}